{"id":433231,"date":"2025-10-02T08:44:09","date_gmt":"2025-10-02T08:44:09","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/433231\/"},"modified":"2025-10-02T08:44:09","modified_gmt":"2025-10-02T08:44:09","slug":"le-chru-de-nancy-inaugure-un-dispositif-de-diagnostic-plus-rapide","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/433231\/","title":{"rendered":"le CHRU de Nancy inaugure un dispositif de diagnostic plus rapide"},"content":{"rendered":"<p>            Par<br \/>\n        <strong><br \/>\n            <a href=\"https:\/\/actu.fr\/auteur\/pierre-emile-bouchy-actu-fr\" title=\"Consulter tous les articles de Paul-Emile Bouchy\" target=\"_blank\" rel=\"noopener\">Paul-Emile Bouchy<\/a><br \/>\n        <\/strong><\/p>\n<p>        Publi\u00e9 le<\/p>\n<p>            2 oct. 2025 \u00e0 10h30        <\/p>\n<p>C\u2019est une avanc\u00e9e importante que lance le <a href=\"https:\/\/actu.fr\/tag\/chru-de-nancy\" target=\"_blank\" rel=\"noopener\">CHRU de Nancy<\/a> et qui va permettre de sauver des vies. Gr\u00e2ce au <strong>dispositif Cellvizio<\/strong>, il sera <strong>plus rapide et plus fiable de diagnostiquer le cancer du poumon chez un patient<\/strong>.<\/p>\n<p class=\" wall-content\">On vous pr\u00e9sente cette technologie dont dispose le centre hospitalier nanc\u00e9ien, <strong>premier centre de chirurgie thoracique en France et en Europe \u00e0 en \u00eatre \u00e9quip\u00e9<\/strong>.<\/p>\n<p>Une technologie qui permet d\u2019atteindre des zones inaccessibles du poumon<\/p>\n<p class=\" wall-content\">Comme l\u2019explique le CHRU de Nancy dans un communiqu\u00e9 de presse, \u00ab\u2009le syst\u00e8me Cellvizio permet, de mani\u00e8re mini-invasive, d\u2019<strong>explorer l\u2019ensemble du poumon et d\u2019observer en temps r\u00e9el l\u2019architecture cellulaire des tissus et nodules<\/strong>\u2009\u00bb.<\/p>\n<p class=\" wall-content\">Cela apporte de nombreux avantages\u2009:<\/p>\n<ul class=\" wall-content\">\n<li>\u00ab\u00a0un diagnostic <strong>plus rapide et plus fiable<\/strong>,<\/li>\n<li>la possibilit\u00e9 de <strong>biopsier des zones tr\u00e8s distales jusque-l\u00e0 inaccessibles<\/strong>,<\/li>\n<li>une orientation chirurgicale facilit\u00e9e gr\u00e2ce au <strong>marquage fluorescent<\/strong>,<\/li>\n<li><strong>une am\u00e9lioration de la qualit\u00e9 de la prise en charge<\/strong> des patients.\u00a0\u00bb<\/li>\n<\/ul>\n<p>Un vrai enjeu de d\u00e9tecter la tumeur le plus t\u00f4t possible<\/p>\n<p class=\" wall-content\">Le cancer du poumon est aujourd\u2019hui \u00ab\u2009le 2e cancer le plus fr\u00e9quent chez l\u2019homme, le 3e chez la femme et reste la premi\u00e8re cause de d\u00e9c\u00e8s par <a href=\"https:\/\/actu.fr\/tag\/cancer\" target=\"_blank\" rel=\"noopener\">cancer<\/a> en France\u2009\u00bb. Pour le corps m\u00e9dical, <strong>le diagnostic pr\u00e9coce du cancer du poumon permet de sauver des vies<\/strong>\u2009:<\/p>\n<p>Votre r\u00e9gion, votre actu !<\/p>\n<p>Recevez chaque jour les infos qui comptent pour vous.<\/p>\n<p>\t<a href=\"https:\/\/actu.fr\/newsletter\" class=\"ac-btn ac-btn--corner ac-btn--medium ac-btn--blue800\" target=\"_blank\" rel=\"noopener\">S&rsquo;incrire<\/a><\/p>\n<blockquote class=\"ac-article-quote wall-content\">\n<p>Le diagnostic tardif est l\u2019un des principaux facteurs expliquant la mortalit\u00e9 \u00e9lev\u00e9e du cancer pulmonaire. Les donn\u00e9es scientifiques le d\u00e9montrent clairement : 92 % des patients survivent \u00e0 5 ans lorsqu\u2019une tumeur est d\u00e9tect\u00e9e \u00e0 un stade inf\u00e9rieur \u00e0 1 cm, contre 60 % lorsque sa taille atteint 4 \u00e0 5 cm\u00a0\u00bb, indique le CHRU de Nancy.<\/p>\n<p>    <strong>CHRU de Nancy<\/strong>\n            <\/p><\/blockquote>\n<p class=\" wall-content\">Le co\u00fbt de ce dispositif est de <strong>296\u2009000\u00a0euros<\/strong> et son acquisition a \u00e9t\u00e9 possible gr\u00e2ce \u00e0 la g\u00e9n\u00e9rosit\u00e9 du Comit\u00e9 54 de Meurthe-et-Moselle de la Ligue contre le cancer et de l\u2019association des motards \u201cUne Rose, un espoir\u201d.<\/p>\n<p class=\" wall-content\">Personnalisez votre actualit\u00e9 en ajoutant vos villes et m\u00e9dias en favori avec <a href=\"https:\/\/moncompte.actu.fr\" title=\"D\u00e9couvez Mon Actu\" rel=\"nofollow noopener\" data-trk=\"{&quot;cta&quot;:{&quot;action&quot;:&quot;https:\\\/\\\/moncompte.actu.fr&quot;,&quot;category&quot;:&quot;mon compte&quot;,&quot;from&quot;:&quot;article footer&quot;,&quot;name&quot;:&quot;Mon actu&quot;,&quot;type&quot;:&quot;cta&quot;}}\" target=\"_blank\">Mon Actu<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Par Paul-Emile Bouchy Publi\u00e9 le 2 oct. 2025 \u00e0 10h30 C\u2019est une avanc\u00e9e importante que lance le CHRU&hellip;\n","protected":false},"author":2,"featured_media":433232,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9635],"tags":[1111,11,101,12765,1777,674,1011,27,775,1702,12,25,71,104],"class_list":{"0":"post-433231","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nancy","8":"tag-actu","9":"tag-actualites","10":"tag-cancer","11":"tag-chru-de-nancy","12":"tag-eu","13":"tag-europe","14":"tag-fr","15":"tag-france","16":"tag-grand-est","17":"tag-nancy","18":"tag-news","19":"tag-republique-francaise","20":"tag-sante","21":"tag-societe"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115303695351164919","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/433231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=433231"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/433231\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/433232"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=433231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=433231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=433231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}